Work

Phase II study of 21 day continuous intravenous infusion (CIVI) topotecan for recurrent pediatric solid tumors: A Children’s Oncology Group Study (COG A09713)

Year: 2005

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2005.23.16_suppl.8523

Authors: S. Bradfield, D. S. Hawkins, J. Whitlock, M. Krailo, J. Franklin, P. C. Adamson

Institutions: Children's Hospital of Los Angeles, Nemours Children's Clinic

Language: English

Topic: Cancer therapeutics and mechanisms

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2285530189

Cites:

Cited by:

Related to: 10